Browse 17 Biotechnology companies funded by New Enterprise Associates. See funding amounts, founder contacts, and investment details.
Tempus develops AI-enabled precision medicine technology that supports clinical decision-making and biomedical research.
Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor pathways.
Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.
Trevi Therapeutics is a clinical-stage biopharmaceutical company that develops drugs for treating uremic pruritus.
AviadoBio transform the lives of people living with neurodegenerative disorders by developing and delivering transformative gene therapies
Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.
SetPoint Medical provides a device-based therapy for rheumatoid arthritis.
Splice Bio develops gene therapies using its Protein Splicing platform for genetic diseases.
Allay Therapeutics offers analgesic products for post-surgical pain management and recuperation.
ChromaCode is a molecular diagnostics company focusing on bioinformatics.
Tune Therapeutics is an epigenetic programming platform for the treatment of disease.
FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.
858 Therapeutics develops small molecule drugs targeting oncology and immunology.
Moximed develops innovative therapies for patients with knee osteoarthritis.
MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.
Our purpose is to make every pregnancy around the world safer.
U.S. Renal Care is a healthcare service provider that focuses on serving patients in dialysis facilities.
View all companies funded by New Enterprise Associates across every industry and funding stage.
View Full New Enterprise Associates Portfolio